Lab Canada

Product News

Enhanced crystallization control improves polymorph screening


Non-destructive evaporation technology called eXalt was developed with partners in the field of pharmaceutical small molecule crystallization. The technology has found application in labs that perform tasks including first time crystallization of amorphous forms, recrystallization of samples which have only a few known forms, removing a hydrate, solvent screening studies to find the most suitable conditions to take forward in development, high throughput co-crystallization screens and studies to confirm stable isoforms. It enables a wide range of solvents and multiple actives to be evaporated all at the same slow rate, and under the same conditions, giving the user unprecedented control of the crystallization process. Genevac


Print this page

Related